We gratefully acknowledge support from
the Simons Foundation and member institutions.
Full-text links:


Current browse context:


Change to browse by:

References & Citations


(what is this?)
CiteULike logo BibSonomy logo Mendeley logo del.icio.us logo Digg logo Reddit logo ScienceWISE logo

Quantitative Biology > Genomics

Title: Turning genome-wide association study findings into opportunities for drug repositioning

Abstract: Drug development is a very costly and lengthy process, while repositioned or repurposed drugs could be brought into clinical practice within a shorter time-frame and at a much reduced cost. The past decade has observed a massive growth in the amount of data from genome-wide association studies (GWAS). The rich information contained in GWAS data has great potential to guide drug discovery or repositioning. Here we provide an overview of different computational approaches which employ GWAS data to guide drug repositioning. These methods include selection of top candidate genes from GWAS as drug targets, deducing drug candidates based on drug-drug and disease-disease similarity, searching for reversed expression profiles between drugs and diseases, pathway-based methods as well as repositioning based on analysis of biological networks. Each method is illustrated with examples, and their respective strengths and limitations are discussed. Finally we discussed several areas for future research.
Subjects: Genomics (q-bio.GN)
Cite as: arXiv:1911.05477 [q-bio.GN]
  (or arXiv:1911.05477v1 [q-bio.GN] for this version)

Submission history

From: Hon-Cheong So [view email]
[v1] Mon, 11 Nov 2019 23:16:52 GMT (388kb)

Link back to: arXiv, form interface, contact.